Sabre Global Technologies knew Ural Airlines had been sanctioned on the day the designation took effect. The travel technology company continued providing services to the Russian carrier for another seven months. Then, when its UK bank blocked payments over sanctions concerns, the company began looking for another way to get paid, which has now cost Sabre Global Technologies Limited (SGTL) £1,000,920.59.
Corpay, formerly known as FleetCor Technologies, and CEO Ronald Clarke have agreed to pay $100 million to resolve a Federal Trade Commission administrative action stemming from the company’s fuel card practices, years after the agency first accused it of charging businesses hidden or unauthorized fees.
The FCA’s new crypto regime does not take effect until October 2027, but firms will have to start making decisions much sooner. With the authorization gateway opening on Sept. 30, the regulator has published guidance explaining which cryptoasset activities fall within the new framework and where FCA authorization may be required.
The UK’s Competition and Markets Authority will seek to give businesses greater certainty over how it regulates while maintaining its willingness to intervene against anti-competitive conduct, Chair Doug Gurr said Wednesday, setting out three commitments for the beginning of his five-year term.
Accenture has agreed to pay the United States $25 million to resolve allegations that its federal contracting business considered race and sex in hiring, promotion and professional development while certifying its compliance with anti-discrimination requirements attached to federal contracts.
Between July and September, the Commodity Futures Trading Commission (CFTC) granted 10 whistleblower awards worth more than $150 million, recognizing individuals whose original information helped the CFTC and other authorities bring successful enforcement actions. The Commission announced the final award determinations Monday, putting a number on what it describes as a record year for a whistleblower program that had entered 2026 carrying a substantial backlog.
Abbott Laboratories has agreed to pay nearly $385 million to settle allegations that it sold infant formula and nutritional products to government programs while failing to meet federal and state requirements at two of its manufacturing facilities, closing a False Claims Act case built around conditions the Justice Department says exposed products to an unacceptable risk of contamination.